Female directors are quicker to recall dangerous medical products

Some 4,500 Food and Drug Administration-approved drugs and devices are pulled from shelves annually — decisions greatly influenced by the presence of women on a firm’s board, according to new research from Kaitlin Wowak, professor of IT, Analytics and Operations.

Published

Related News & Stories

All News & Stories